

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 6.79677785 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.70928897 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.56318318 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.50840399 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.75883064 |
| 6 | vocalization behavior (GO:0071625) | 5.66741801 |
| 7 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.62689684 |
| 8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.60767101 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.55078474 |
| 10 | regulation of neuronal synaptic plasticity (GO:0048168) | 5.53518872 |
| 11 | regulation of synapse structural plasticity (GO:0051823) | 5.32727449 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 5.30378135 |
| 13 | glutamate secretion (GO:0014047) | 5.27301611 |
| 14 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 5.23862743 |
| 15 | exploration behavior (GO:0035640) | 5.07504900 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.89652904 |
| 17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.85937962 |
| 18 | dendritic spine morphogenesis (GO:0060997) | 4.82418309 |
| 19 | protein localization to synapse (GO:0035418) | 4.76954879 |
| 20 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.56268314 |
| 21 | long-term memory (GO:0007616) | 4.53191068 |
| 22 | neuronal action potential propagation (GO:0019227) | 4.50950549 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 4.46397884 |
| 24 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.45141395 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 4.43322036 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.37551379 |
| 27 | positive regulation of membrane potential (GO:0045838) | 4.34971784 |
| 28 | neurotransmitter secretion (GO:0007269) | 4.33092115 |
| 29 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.31812373 |
| 30 | amino acid import (GO:0043090) | 4.31081720 |
| 31 | cerebellar granule cell differentiation (GO:0021707) | 4.27200862 |
| 32 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.25895042 |
| 33 | regulation of synaptic plasticity (GO:0048167) | 4.23111931 |
| 34 | potassium ion import (GO:0010107) | 4.09414675 |
| 35 | glutamate receptor signaling pathway (GO:0007215) | 4.09132378 |
| 36 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.07062991 |
| 37 | layer formation in cerebral cortex (GO:0021819) | 4.03445433 |
| 38 | neuromuscular process controlling balance (GO:0050885) | 4.01758388 |
| 39 | neuron-neuron synaptic transmission (GO:0007270) | 4.00041292 |
| 40 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.96732573 |
| 41 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.96283066 |
| 42 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.96126563 |
| 43 | dendritic spine organization (GO:0097061) | 3.93759324 |
| 44 | regulation of postsynaptic membrane potential (GO:0060078) | 3.91165571 |
| 45 | neuromuscular synaptic transmission (GO:0007274) | 3.90101428 |
| 46 | potassium ion homeostasis (GO:0055075) | 3.84923719 |
| 47 | regulation of synapse maturation (GO:0090128) | 3.83124329 |
| 48 | positive regulation of synapse maturation (GO:0090129) | 3.73977074 |
| 49 | cellular potassium ion homeostasis (GO:0030007) | 3.71886050 |
| 50 | activation of protein kinase A activity (GO:0034199) | 3.70831759 |
| 51 | proline transport (GO:0015824) | 3.67491920 |
| 52 | postsynaptic membrane organization (GO:0001941) | 3.67081843 |
| 53 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.66597644 |
| 54 | long-term synaptic potentiation (GO:0060291) | 3.66133219 |
| 55 | sodium ion export (GO:0071436) | 3.65750991 |
| 56 | L-amino acid import (GO:0043092) | 3.65212779 |
| 57 | central nervous system myelination (GO:0022010) | 3.65037582 |
| 58 | axon ensheathment in central nervous system (GO:0032291) | 3.65037582 |
| 59 | auditory behavior (GO:0031223) | 3.58385858 |
| 60 | regulation of dendritic spine development (GO:0060998) | 3.57538415 |
| 61 | prepulse inhibition (GO:0060134) | 3.57493467 |
| 62 | regulation of ARF protein signal transduction (GO:0032012) | 3.55661752 |
| 63 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.55632784 |
| 64 | positive regulation of dendritic spine development (GO:0060999) | 3.55326354 |
| 65 | neuron cell-cell adhesion (GO:0007158) | 3.53131690 |
| 66 | positive regulation of neurotransmitter transport (GO:0051590) | 3.52911788 |
| 67 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.52567707 |
| 68 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.52050824 |
| 69 | regulation of cell communication by electrical coupling (GO:0010649) | 3.48389936 |
| 70 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.48016509 |
| 71 | neuronal ion channel clustering (GO:0045161) | 3.46080033 |
| 72 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.45782329 |
| 73 | transmission of nerve impulse (GO:0019226) | 3.42249867 |
| 74 | gamma-aminobutyric acid transport (GO:0015812) | 3.41539840 |
| 75 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.39375875 |
| 76 | regulation of neurotransmitter secretion (GO:0046928) | 3.38087819 |
| 77 | neurotransmitter transport (GO:0006836) | 3.36129350 |
| 78 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.35084939 |
| 79 | chemosensory behavior (GO:0007635) | 3.34263360 |
| 80 | behavioral fear response (GO:0001662) | 3.33599580 |
| 81 | behavioral defense response (GO:0002209) | 3.33599580 |
| 82 | response to auditory stimulus (GO:0010996) | 3.33325132 |
| 83 | synaptic vesicle endocytosis (GO:0048488) | 3.28660567 |
| 84 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.28352467 |
| 85 | regulation of female receptivity (GO:0045924) | 3.27834985 |
| 86 | regulation of vesicle fusion (GO:0031338) | 3.25596617 |
| 87 | membrane depolarization (GO:0051899) | 3.24456983 |
| 88 | regulation of neurotransmitter levels (GO:0001505) | 3.22856436 |
| 89 | cellular sodium ion homeostasis (GO:0006883) | 3.21110579 |
| 90 | positive regulation of synaptic transmission (GO:0050806) | 3.20919198 |
| 91 | learning (GO:0007612) | 3.20265055 |
| 92 | regulation of neurotransmitter transport (GO:0051588) | 3.20231444 |
| 93 | cell communication by electrical coupling (GO:0010644) | 3.18636083 |
| 94 | acidic amino acid transport (GO:0015800) | 3.18559592 |
| 95 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.18304608 |
| 96 | regulation of synaptic transmission (GO:0050804) | 3.17304908 |
| 97 | innervation (GO:0060384) | 3.12226216 |
| 98 | positive regulation of dendrite development (GO:1900006) | 3.11650906 |
| 99 | neuromuscular process controlling posture (GO:0050884) | 3.09502526 |
| 100 | regulation of oxidative phosphorylation (GO:0002082) | 3.09075868 |
| 101 | signal complex assembly (GO:0007172) | 3.08955820 |
| 102 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.08724703 |
| 103 | neurotransmitter uptake (GO:0001504) | 3.08593165 |
| 104 | neuromuscular process (GO:0050905) | 3.08433069 |
| 105 | vesicle docking involved in exocytosis (GO:0006904) | 3.07800979 |
| 106 | vesicle transport along microtubule (GO:0047496) | 3.07457303 |
| 107 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.06652518 |
| 108 | positive regulation of fibroblast migration (GO:0010763) | 3.05985277 |
| 109 | neuron recognition (GO:0008038) | 3.04620509 |
| 110 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.03102505 |
| 111 | dendrite morphogenesis (GO:0048813) | 3.02669714 |
| 112 | visual learning (GO:0008542) | 3.01240587 |
| 113 | glycine transport (GO:0015816) | 3.01182776 |
| 114 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.00641735 |
| 115 | fear response (GO:0042596) | 3.00128749 |
| 116 | membrane depolarization during action potential (GO:0086010) | 2.99293428 |
| 117 | membrane hyperpolarization (GO:0060081) | 2.97336636 |
| 118 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.96025209 |
| 119 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.95457320 |
| 120 | intraspecies interaction between organisms (GO:0051703) | 2.95146692 |
| 121 | social behavior (GO:0035176) | 2.95146692 |
| 122 | long term synaptic depression (GO:0060292) | 2.93788718 |
| 123 | detection of calcium ion (GO:0005513) | 2.93019753 |
| 124 | positive regulation of vesicle fusion (GO:0031340) | 2.92449850 |
| 125 | synaptic transmission (GO:0007268) | 2.92309244 |
| 126 | phosphorelay signal transduction system (GO:0000160) | 2.90721855 |
| 127 | regulation of exocytosis (GO:0017157) | 2.90643140 |
| 128 | regulation of dendrite morphogenesis (GO:0048814) | 2.88309473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.99990382 |
| 2 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.37150378 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.18173803 |
| 4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.13652111 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12442538 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.89009440 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.89009440 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.85956186 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.83714735 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.82947365 |
| 11 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.76135624 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.70455768 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.65766052 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.64770648 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.63826804 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.50905738 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47547415 |
| 18 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.43022130 |
| 19 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.39289491 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.38079132 |
| 21 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.37747238 |
| 22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.32990780 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.32024773 |
| 24 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.28153748 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.13050049 |
| 26 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.89424049 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.84432663 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.78817499 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72516260 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.64966365 |
| 31 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.55579857 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48669705 |
| 33 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.48582587 |
| 34 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.48100051 |
| 35 | KDM2B_26808549_Chip-Seq_K562_Human | 1.44970780 |
| 36 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.42455792 |
| 37 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.40933898 |
| 38 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.40427052 |
| 39 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.36951780 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36448832 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36296850 |
| 42 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.36254743 |
| 43 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33897387 |
| 44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33165596 |
| 45 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.27357559 |
| 46 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.26291393 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.26262503 |
| 48 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.25176970 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.23112399 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22208908 |
| 51 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20227702 |
| 52 | AR_19668381_ChIP-Seq_PC3_Human | 1.19579434 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19286079 |
| 54 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.18560545 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.18101560 |
| 56 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.17400822 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16310648 |
| 58 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.15851877 |
| 59 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11415953 |
| 60 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.09870898 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08630929 |
| 62 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07516279 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07378014 |
| 64 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06883091 |
| 65 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06691533 |
| 66 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06615995 |
| 67 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05729374 |
| 68 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05005913 |
| 69 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04603740 |
| 70 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04455989 |
| 71 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.04400062 |
| 72 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.03841502 |
| 73 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.03609334 |
| 74 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02702725 |
| 75 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02479971 |
| 76 | P68_20966046_ChIP-Seq_HELA_Human | 1.02247499 |
| 77 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.01465202 |
| 78 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01389680 |
| 79 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.99019456 |
| 80 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98837966 |
| 81 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98403387 |
| 82 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.98050630 |
| 83 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98032342 |
| 84 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.96994191 |
| 85 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94923043 |
| 86 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94458208 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94317187 |
| 88 | P300_19829295_ChIP-Seq_ESCs_Human | 0.94166531 |
| 89 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.93370733 |
| 90 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92290941 |
| 91 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92258593 |
| 92 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.92121360 |
| 93 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.91559173 |
| 94 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.90142592 |
| 95 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90029303 |
| 96 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89290493 |
| 97 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.88457700 |
| 98 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88448160 |
| 99 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88303963 |
| 100 | TCF4_23295773_ChIP-Seq_U87_Human | 0.88202243 |
| 101 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87757121 |
| 102 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87054674 |
| 103 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.87021782 |
| 104 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.87002729 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86783063 |
| 106 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86262358 |
| 107 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85978634 |
| 108 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.85082710 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84875604 |
| 110 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84785037 |
| 111 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.84699125 |
| 112 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.82458544 |
| 113 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82369053 |
| 114 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.82029352 |
| 115 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81947173 |
| 116 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.81260786 |
| 117 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.80488845 |
| 118 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80436275 |
| 119 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.80269411 |
| 120 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80187707 |
| 121 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.80095055 |
| 122 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.79934811 |
| 123 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.79447146 |
| 124 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.79306756 |
| 125 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.78738429 |
| 126 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.77951456 |
| 127 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.77946265 |
| 128 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77864309 |
| 129 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.76215246 |
| 130 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.76097881 |
| 131 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.75232275 |
| 132 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73379310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 8.62325587 |
| 2 | MP0003880_abnormal_central_pattern | 4.74919842 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.56297498 |
| 4 | MP0002822_catalepsy | 4.49820982 |
| 5 | MP0004270_analgesia | 3.87465755 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.76362968 |
| 7 | MP0009745_abnormal_behavioral_response | 3.70402612 |
| 8 | MP0002064_seizures | 3.29955492 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.87707011 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.69833727 |
| 11 | MP0001486_abnormal_startle_reflex | 2.67861727 |
| 12 | MP0009046_muscle_twitch | 2.64120640 |
| 13 | MP0002272_abnormal_nervous_system | 2.56508979 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.40354711 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.37894052 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.24278390 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.21390264 |
| 18 | MP0000749_muscle_degeneration | 2.06128801 |
| 19 | MP0008569_lethality_at_weaning | 1.95871620 |
| 20 | MP0002736_abnormal_nociception_after | 1.95093877 |
| 21 | MP0002735_abnormal_chemical_nociception | 1.94705267 |
| 22 | MP0004858_abnormal_nervous_system | 1.94533014 |
| 23 | MP0004811_abnormal_neuron_physiology | 1.91433251 |
| 24 | MP0001440_abnormal_grooming_behavior | 1.91357558 |
| 25 | MP0002909_abnormal_adrenal_gland | 1.90610223 |
| 26 | MP0003075_altered_response_to | 1.78899543 |
| 27 | MP0001970_abnormal_pain_threshold | 1.78868654 |
| 28 | MP0003329_amyloid_beta_deposits | 1.75936099 |
| 29 | MP0004145_abnormal_muscle_electrophysio | 1.72195040 |
| 30 | MP0002733_abnormal_thermal_nociception | 1.69189922 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.64985185 |
| 32 | MP0003879_abnormal_hair_cell | 1.64239716 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.61230660 |
| 34 | MP0004885_abnormal_endolymph | 1.58091753 |
| 35 | MP0002067_abnormal_sensory_capabilities | 1.56513521 |
| 36 | MP0004924_abnormal_behavior | 1.51445268 |
| 37 | MP0005386_behavior/neurological_phenoty | 1.51445268 |
| 38 | MP0003633_abnormal_nervous_system | 1.50359463 |
| 39 | MP0000955_abnormal_spinal_cord | 1.43254082 |
| 40 | MP0000778_abnormal_nervous_system | 1.42816706 |
| 41 | MP0002184_abnormal_innervation | 1.42681264 |
| 42 | MP0002066_abnormal_motor_capabilities/c | 1.37004207 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.31193589 |
| 44 | MP0003787_abnormal_imprinting | 1.29039030 |
| 45 | MP0003123_paternal_imprinting | 1.27172980 |
| 46 | MP0003631_nervous_system_phenotype | 1.20670381 |
| 47 | MP0010234_abnormal_vibrissa_follicle | 1.18835583 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.17645150 |
| 49 | MP0000747_muscle_weakness | 1.16078013 |
| 50 | MP0001177_atelectasis | 1.15554096 |
| 51 | MP0004036_abnormal_muscle_relaxation | 1.14531771 |
| 52 | MP0001905_abnormal_dopamine_level | 1.13957304 |
| 53 | MP0001529_abnormal_vocalization | 1.13625960 |
| 54 | MP0001984_abnormal_olfaction | 1.12501342 |
| 55 | MP0008874_decreased_physiological_sensi | 1.11814904 |
| 56 | MP0008872_abnormal_physiological_respon | 1.07889314 |
| 57 | MP0008961_abnormal_basal_metabolism | 1.04304857 |
| 58 | MP0003690_abnormal_glial_cell | 1.02782544 |
| 59 | MP0002152_abnormal_brain_morphology | 1.01697737 |
| 60 | MP0003283_abnormal_digestive_organ | 1.00615475 |
| 61 | MP0001502_abnormal_circadian_rhythm | 0.99480219 |
| 62 | MP0004510_myositis | 0.98772019 |
| 63 | MP0002069_abnormal_eating/drinking_beha | 0.96583697 |
| 64 | MP0003646_muscle_fatigue | 0.94198024 |
| 65 | MP0000759_abnormal_skeletal_muscle | 0.94089275 |
| 66 | MP0005535_abnormal_body_temperature | 0.92064828 |
| 67 | MP0005645_abnormal_hypothalamus_physiol | 0.90861572 |
| 68 | MP0000920_abnormal_myelination | 0.88173848 |
| 69 | MP0004147_increased_porphyrin_level | 0.88141675 |
| 70 | MP0000751_myopathy | 0.87685793 |
| 71 | MP0000569_abnormal_digit_pigmentation | 0.86485159 |
| 72 | MP0002090_abnormal_vision | 0.85558024 |
| 73 | MP0002638_abnormal_pupillary_reflex | 0.83513124 |
| 74 | MP0000604_amyloidosis | 0.82591401 |
| 75 | MP0002269_muscular_atrophy | 0.82521816 |
| 76 | MP0004087_abnormal_muscle_fiber | 0.82357428 |
| 77 | MP0004142_abnormal_muscle_tone | 0.81926857 |
| 78 | MP0002837_dystrophic_cardiac_calcinosis | 0.81686889 |
| 79 | MP0004085_abnormal_heartbeat | 0.81370695 |
| 80 | MP0000013_abnormal_adipose_tissue | 0.78193766 |
| 81 | MP0005409_darkened_coat_color | 0.77726641 |
| 82 | MP0005620_abnormal_muscle_contractility | 0.77646710 |
| 83 | MP0002229_neurodegeneration | 0.76584490 |
| 84 | MP0002106_abnormal_muscle_physiology | 0.75284953 |
| 85 | MP0005166_decreased_susceptibility_to | 0.75276776 |
| 86 | MP0003634_abnormal_glial_cell | 0.75084094 |
| 87 | MP0001986_abnormal_taste_sensitivity | 0.72855795 |
| 88 | MP0003632_abnormal_nervous_system | 0.72675794 |
| 89 | MP0006276_abnormal_autonomic_nervous | 0.70765956 |
| 90 | MP0004084_abnormal_cardiac_muscle | 0.68276658 |
| 91 | MP0005369_muscle_phenotype | 0.68019785 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 0.67750018 |
| 93 | MP0005623_abnormal_meninges_morphology | 0.66440603 |
| 94 | MP0010386_abnormal_urinary_bladder | 0.65460750 |
| 95 | MP0003172_abnormal_lysosome_physiology | 0.65246176 |
| 96 | MP0001963_abnormal_hearing_physiology | 0.64367185 |
| 97 | MP0005394_taste/olfaction_phenotype | 0.63743775 |
| 98 | MP0005499_abnormal_olfactory_system | 0.63743775 |
| 99 | MP0004484_altered_response_of | 0.63075605 |
| 100 | MP0001188_hyperpigmentation | 0.61639886 |
| 101 | MP0001664_abnormal_digestion | 0.61629823 |
| 102 | MP0004130_abnormal_muscle_cell | 0.60186061 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.58359440 |
| 104 | MP0005330_cardiomyopathy | 0.57252562 |
| 105 | MP0004043_abnormal_pH_regulation | 0.56788924 |
| 106 | MP0003122_maternal_imprinting | 0.54876934 |
| 107 | MP0005551_abnormal_eye_electrophysiolog | 0.53083236 |
| 108 | MP0004215_abnormal_myocardial_fiber | 0.52971094 |
| 109 | MP0001348_abnormal_lacrimal_gland | 0.52519944 |
| 110 | MP0003183_abnormal_peptide_metabolism | 0.52077673 |
| 111 | MP0001765_abnormal_ion_homeostasis | 0.52039555 |
| 112 | MP0001485_abnormal_pinna_reflex | 0.51754660 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.48889380 |
| 114 | MP0002752_abnormal_somatic_nervous | 0.47899680 |
| 115 | MP0001346_abnormal_lacrimal_gland | 0.47580763 |
| 116 | MP0000631_abnormal_neuroendocrine_gland | 0.47419484 |
| 117 | MP0004233_abnormal_muscle_weight | 0.47058994 |
| 118 | MP0002234_abnormal_pharynx_morphology | 0.47023573 |
| 119 | MP0003956_abnormal_body_size | 0.46942298 |
| 120 | MP0004742_abnormal_vestibular_system | 0.46563003 |
| 121 | MP0010769_abnormal_survival | 0.45572292 |
| 122 | MP0001943_abnormal_respiration | 0.44883716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 9.39882257 |
| 2 | Focal motor seizures (HP:0011153) | 8.20694563 |
| 3 | Focal seizures (HP:0007359) | 5.87565791 |
| 4 | Visual hallucinations (HP:0002367) | 5.35149492 |
| 5 | Action tremor (HP:0002345) | 4.53372924 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.31947645 |
| 7 | Impaired vibration sensation in the lower limbs (HP:0002166) | 4.15470929 |
| 8 | Febrile seizures (HP:0002373) | 4.14963831 |
| 9 | Atonic seizures (HP:0010819) | 4.08494135 |
| 10 | Muscle fiber inclusion bodies (HP:0100299) | 4.04106488 |
| 11 | Exercise-induced myalgia (HP:0003738) | 4.00797015 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.98007695 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.97839239 |
| 14 | Absence seizures (HP:0002121) | 3.88033942 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.87192015 |
| 16 | Annular pancreas (HP:0001734) | 3.79148266 |
| 17 | Ankle clonus (HP:0011448) | 3.78127217 |
| 18 | Depression (HP:0000716) | 3.74601084 |
| 19 | Poor eye contact (HP:0000817) | 3.66768314 |
| 20 | Abnormality of the lower motor neuron (HP:0002366) | 3.65041649 |
| 21 | Dialeptic seizures (HP:0011146) | 3.61479381 |
| 22 | Nemaline bodies (HP:0003798) | 3.59695808 |
| 23 | Hyporeflexia of lower limbs (HP:0002600) | 3.54397869 |
| 24 | Papilledema (HP:0001085) | 3.53579305 |
| 25 | Exercise-induced muscle cramps (HP:0003710) | 3.46898380 |
| 26 | Dysmetria (HP:0001310) | 3.44565675 |
| 27 | Anxiety (HP:0000739) | 3.41117134 |
| 28 | Supranuclear gaze palsy (HP:0000605) | 3.40272151 |
| 29 | Postural instability (HP:0002172) | 3.40230629 |
| 30 | Broad-based gait (HP:0002136) | 3.34857092 |
| 31 | Dysdiadochokinesis (HP:0002075) | 3.34690204 |
| 32 | Gaze-evoked nystagmus (HP:0000640) | 3.34224571 |
| 33 | Torticollis (HP:0000473) | 3.31888293 |
| 34 | Cerebral hypomyelination (HP:0006808) | 3.31240042 |
| 35 | Impaired social interactions (HP:0000735) | 3.29582127 |
| 36 | Abnormal social behavior (HP:0012433) | 3.29582127 |
| 37 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.26520211 |
| 38 | Focal dystonia (HP:0004373) | 3.23347927 |
| 39 | Tetraplegia (HP:0002445) | 3.13679767 |
| 40 | Ventricular fibrillation (HP:0001663) | 3.05468601 |
| 41 | Amblyopia (HP:0000646) | 3.04310695 |
| 42 | Urinary urgency (HP:0000012) | 3.01581758 |
| 43 | EMG: myopathic abnormalities (HP:0003458) | 2.98432280 |
| 44 | Intention tremor (HP:0002080) | 2.97040790 |
| 45 | Abnormal eating behavior (HP:0100738) | 2.91949925 |
| 46 | Stereotypic behavior (HP:0000733) | 2.91371946 |
| 47 | Mutism (HP:0002300) | 2.87041026 |
| 48 | Megalencephaly (HP:0001355) | 2.86830322 |
| 49 | Akinesia (HP:0002304) | 2.85416742 |
| 50 | Impaired vibratory sensation (HP:0002495) | 2.84254855 |
| 51 | Truncal ataxia (HP:0002078) | 2.79864750 |
| 52 | Impaired smooth pursuit (HP:0007772) | 2.79783134 |
| 53 | Myopathic facies (HP:0002058) | 2.79368457 |
| 54 | Pointed chin (HP:0000307) | 2.78701386 |
| 55 | Limb dystonia (HP:0002451) | 2.77467696 |
| 56 | Bundle branch block (HP:0011710) | 2.77301762 |
| 57 | Craniofacial dystonia (HP:0012179) | 2.75658647 |
| 58 | Bradykinesia (HP:0002067) | 2.73323681 |
| 59 | Type 1 muscle fiber predominance (HP:0003803) | 2.72873866 |
| 60 | Spastic gait (HP:0002064) | 2.64993232 |
| 61 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.63705179 |
| 62 | Ankyloglossia (HP:0010296) | 2.61473386 |
| 63 | Hemiplegia (HP:0002301) | 2.59673947 |
| 64 | Sudden death (HP:0001699) | 2.57282108 |
| 65 | Resting tremor (HP:0002322) | 2.54146643 |
| 66 | Frequent falls (HP:0002359) | 2.52739875 |
| 67 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.50824839 |
| 68 | Scanning speech (HP:0002168) | 2.47083051 |
| 69 | Hyperventilation (HP:0002883) | 2.44406047 |
| 70 | Muscle fiber splitting (HP:0003555) | 2.43328738 |
| 71 | Foot dorsiflexor weakness (HP:0009027) | 2.42907741 |
| 72 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.41744893 |
| 73 | Neurofibrillary tangles (HP:0002185) | 2.39183127 |
| 74 | Genetic anticipation (HP:0003743) | 2.38259320 |
| 75 | Cerebral inclusion bodies (HP:0100314) | 2.38191115 |
| 76 | Calf muscle hypertrophy (HP:0008981) | 2.35609350 |
| 77 | Dysmetric saccades (HP:0000641) | 2.34378594 |
| 78 | Abnormality of the foot musculature (HP:0001436) | 2.33794363 |
| 79 | Lower limb asymmetry (HP:0100559) | 2.31555561 |
| 80 | Distal arthrogryposis (HP:0005684) | 2.30761432 |
| 81 | Hemiparesis (HP:0001269) | 2.28841913 |
| 82 | Insomnia (HP:0100785) | 2.27559412 |
| 83 | Obstructive sleep apnea (HP:0002870) | 2.26723404 |
| 84 | Muscle stiffness (HP:0003552) | 2.26544911 |
| 85 | Progressive inability to walk (HP:0002505) | 2.21005825 |
| 86 | Incomplete penetrance (HP:0003829) | 2.19831461 |
| 87 | Difficulty running (HP:0009046) | 2.18617717 |
| 88 | Abnormality of the periventricular white matter (HP:0002518) | 2.17576019 |
| 89 | Scapular winging (HP:0003691) | 2.17349404 |
| 90 | Lower limb muscle weakness (HP:0007340) | 2.16960243 |
| 91 | Drooling (HP:0002307) | 2.16807735 |
| 92 | Excessive salivation (HP:0003781) | 2.16807735 |
| 93 | Abnormality of binocular vision (HP:0011514) | 2.16275181 |
| 94 | Diplopia (HP:0000651) | 2.16275181 |
| 95 | Abnormality of the calf musculature (HP:0001430) | 2.15743230 |
| 96 | Abnormal EKG (HP:0003115) | 2.12551417 |
| 97 | Diminished motivation (HP:0000745) | 2.11037388 |
| 98 | Epileptiform EEG discharges (HP:0011182) | 2.10301129 |
| 99 | Generalized myoclonic seizures (HP:0002123) | 2.08572814 |
| 100 | Fetal akinesia sequence (HP:0001989) | 2.08387408 |
| 101 | Insidious onset (HP:0003587) | 2.08128072 |
| 102 | Termporal pattern (HP:0011008) | 2.08128072 |
| 103 | Lower limb amyotrophy (HP:0007210) | 2.07333692 |
| 104 | Status epilepticus (HP:0002133) | 2.06398246 |
| 105 | Rapidly progressive (HP:0003678) | 2.05891932 |
| 106 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.04469926 |
| 107 | Peripheral hypomyelination (HP:0007182) | 2.03013635 |
| 108 | Clonus (HP:0002169) | 2.01837054 |
| 109 | EEG with generalized epileptiform discharges (HP:0011198) | 2.00386890 |
| 110 | Neck muscle weakness (HP:0000467) | 1.99810587 |
| 111 | Sleep apnea (HP:0010535) | 1.99060006 |
| 112 | Delusions (HP:0000746) | 1.98812246 |
| 113 | Gait ataxia (HP:0002066) | 1.98087483 |
| 114 | Rimmed vacuoles (HP:0003805) | 1.97889548 |
| 115 | Abnormal atrioventricular conduction (HP:0005150) | 1.97721997 |
| 116 | Increased variability in muscle fiber diameter (HP:0003557) | 1.97053057 |
| 117 | Hypsarrhythmia (HP:0002521) | 1.95543852 |
| 118 | Rigidity (HP:0002063) | 1.94042481 |
| 119 | Apathy (HP:0000741) | 1.93293874 |
| 120 | Polygenic inheritance (HP:0010982) | 1.90630917 |
| 121 | Spinal canal stenosis (HP:0003416) | 1.89478551 |
| 122 | Abnormality of saccadic eye movements (HP:0000570) | 1.88965036 |
| 123 | Abnormality of oral frenula (HP:0000190) | 1.87721005 |
| 124 | Anosmia (HP:0000458) | 1.86058740 |
| 125 | Achilles tendon contracture (HP:0001771) | 1.83134198 |
| 126 | Intellectual disability, profound (HP:0002187) | 1.79317876 |
| 127 | Absent speech (HP:0001344) | 1.78210422 |
| 128 | Spastic tetraparesis (HP:0001285) | 1.77532929 |
| 129 | Neuronal loss in central nervous system (HP:0002529) | 1.75958315 |
| 130 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.74758957 |
| 131 | Heart block (HP:0012722) | 1.74286679 |
| 132 | Increased circulating renin level (HP:0000848) | 1.72042366 |
| 133 | Aplasia involving bones of the extremities (HP:0009825) | 1.70364913 |
| 134 | Aplasia of the phalanges of the hand (HP:0009802) | 1.70364913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.87834405 |
| 2 | NTRK3 | 4.61423917 |
| 3 | MAP3K9 | 3.99870190 |
| 4 | PRKD3 | 3.45453955 |
| 5 | DAPK2 | 2.95165665 |
| 6 | KSR2 | 2.93185939 |
| 7 | MINK1 | 2.63186405 |
| 8 | OBSCN | 2.60279702 |
| 9 | CAMKK1 | 2.31046008 |
| 10 | PAK6 | 2.28861549 |
| 11 | MAP3K4 | 2.19806142 |
| 12 | RIPK4 | 2.03358173 |
| 13 | MAP3K13 | 1.96468804 |
| 14 | ARAF | 1.91222587 |
| 15 | MARK1 | 1.90477416 |
| 16 | KSR1 | 1.82323309 |
| 17 | NTRK1 | 1.80220065 |
| 18 | PRPF4B | 1.79733007 |
| 19 | DAPK1 | 1.74003791 |
| 20 | NTRK2 | 1.73238695 |
| 21 | CDK5 | 1.63752725 |
| 22 | MAP2K7 | 1.61892509 |
| 23 | MAP3K2 | 1.57856843 |
| 24 | STK38 | 1.57055412 |
| 25 | FES | 1.56996285 |
| 26 | TYRO3 | 1.41824074 |
| 27 | MAP2K4 | 1.40778180 |
| 28 | MAPK12 | 1.37983192 |
| 29 | RAF1 | 1.29893898 |
| 30 | TAOK1 | 1.26106933 |
| 31 | MAP3K12 | 1.25360712 |
| 32 | CAMK1 | 1.21038085 |
| 33 | SIK2 | 1.18750666 |
| 34 | PTK2B | 1.17466464 |
| 35 | PRKCG | 1.13969844 |
| 36 | TNIK | 1.13472799 |
| 37 | GRK5 | 1.11052999 |
| 38 | PRKCH | 1.00448473 |
| 39 | PDK1 | 0.99373585 |
| 40 | PINK1 | 0.98639455 |
| 41 | PLK2 | 0.98517604 |
| 42 | CDK19 | 0.98238074 |
| 43 | ALK | 0.92392248 |
| 44 | UHMK1 | 0.91405500 |
| 45 | STK11 | 0.87956234 |
| 46 | CDK15 | 0.86439077 |
| 47 | CAMK2A | 0.86185686 |
| 48 | PDPK1 | 0.86080522 |
| 49 | CDK18 | 0.85743923 |
| 50 | LMTK2 | 0.84087622 |
| 51 | CAMK2B | 0.82197136 |
| 52 | SGK223 | 0.82180402 |
| 53 | SGK494 | 0.82180402 |
| 54 | MAP3K1 | 0.82019279 |
| 55 | MAP3K7 | 0.81520161 |
| 56 | CDK14 | 0.79352649 |
| 57 | RET | 0.78088929 |
| 58 | CCNB1 | 0.76177600 |
| 59 | CDK11A | 0.75535239 |
| 60 | MAPK13 | 0.73982030 |
| 61 | BMPR2 | 0.72434080 |
| 62 | SGK3 | 0.72431044 |
| 63 | MAP3K11 | 0.70385147 |
| 64 | NME1 | 0.70098089 |
| 65 | SGK1 | 0.69716001 |
| 66 | NEK1 | 0.69024383 |
| 67 | BRSK1 | 0.68883716 |
| 68 | CAMKK2 | 0.67484424 |
| 69 | SGK2 | 0.65596305 |
| 70 | CASK | 0.65464740 |
| 71 | LATS2 | 0.64981841 |
| 72 | MARK2 | 0.64567493 |
| 73 | PKN1 | 0.64394823 |
| 74 | CAMK4 | 0.63910247 |
| 75 | PAK3 | 0.63522362 |
| 76 | RIPK1 | 0.60961688 |
| 77 | DMPK | 0.59148386 |
| 78 | TNK2 | 0.57678911 |
| 79 | LIMK1 | 0.56358566 |
| 80 | NEK6 | 0.56109991 |
| 81 | TTN | 0.55556596 |
| 82 | MAP2K1 | 0.54862131 |
| 83 | PRKG2 | 0.54433148 |
| 84 | PHKG1 | 0.53735060 |
| 85 | PHKG2 | 0.53735060 |
| 86 | DAPK3 | 0.52447802 |
| 87 | MAP2K6 | 0.51704695 |
| 88 | RPS6KA3 | 0.51243460 |
| 89 | DYRK1A | 0.48902104 |
| 90 | DDR2 | 0.48691294 |
| 91 | FYN | 0.48274923 |
| 92 | PRKCZ | 0.46997162 |
| 93 | OXSR1 | 0.46310695 |
| 94 | MOS | 0.44557154 |
| 95 | MAPK10 | 0.43821439 |
| 96 | ROCK2 | 0.43653437 |
| 97 | ROCK1 | 0.43448880 |
| 98 | PRKD2 | 0.43339880 |
| 99 | PNCK | 0.43302278 |
| 100 | IRAK2 | 0.39184820 |
| 101 | TRIB3 | 0.38738112 |
| 102 | FGR | 0.38065371 |
| 103 | FER | 0.36858744 |
| 104 | BRAF | 0.34918200 |
| 105 | CAMK2G | 0.34878071 |
| 106 | CDC42BPA | 0.34602551 |
| 107 | AKT2 | 0.33421423 |
| 108 | CAMK2D | 0.33294165 |
| 109 | RPS6KB1 | 0.32557406 |
| 110 | PDGFRA | 0.32516557 |
| 111 | TAOK2 | 0.32050762 |
| 112 | PRKCE | 0.30406473 |
| 113 | PRKCA | 0.28882650 |
| 114 | BMX | 0.28626739 |
| 115 | PRKCB | 0.28401940 |
| 116 | SCYL2 | 0.28279875 |
| 117 | PRKG1 | 0.28195874 |
| 118 | TESK1 | 0.26615786 |
| 119 | MAPK4 | 0.24875877 |
| 120 | MAPK8 | 0.24474073 |
| 121 | ICK | 0.22377599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 3.25103120 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.07387223 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.94528492 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.90578477 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.79137918 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.63569577 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.60872165 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.47364300 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.42989144 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.40669269 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.24640698 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.20411406 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.13525411 |
| 14 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 2.11564018 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.09575915 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.09440683 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.07655460 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 2.04561860 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.79672298 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.78757094 |
| 21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.72723592 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.70256561 |
| 23 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.64393883 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.62911047 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.61814927 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.58643906 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.53480375 |
| 28 | Glioma_Homo sapiens_hsa05214 | 1.46584514 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.39669231 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.35119519 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.34911955 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32627948 |
| 33 | Taste transduction_Homo sapiens_hsa04742 | 1.28590955 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22624569 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.17784811 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.17556028 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.15317968 |
| 38 | Melanogenesis_Homo sapiens_hsa04916 | 1.11660250 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10969065 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10463720 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09094726 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.08632896 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01926386 |
| 44 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00060248 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98092568 |
| 46 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.96085356 |
| 47 | Axon guidance_Homo sapiens_hsa04360 | 0.92945275 |
| 48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87482236 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87094129 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.86664886 |
| 51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.86346737 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.86054379 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83212235 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79765674 |
| 55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75626304 |
| 56 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.74631863 |
| 57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73447914 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72880437 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72679331 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72585390 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71322965 |
| 62 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71207521 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70288094 |
| 64 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.69265318 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.68230205 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66930142 |
| 67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65270474 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65053607 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64509104 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.62811289 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62521556 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59820805 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.59226616 |
| 74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58310150 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.53551220 |
| 76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53441513 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52262284 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49630062 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.49283200 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.48622415 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48033643 |
| 82 | Alcoholism_Homo sapiens_hsa05034 | 0.47370386 |
| 83 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.45548759 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45455034 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.44736207 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44721519 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44558609 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44310447 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43126733 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42281125 |
| 91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42074659 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39743538 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38229942 |
| 94 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38012824 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.37820675 |
| 96 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.37578228 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36682157 |
| 98 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36108244 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36012098 |
| 100 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35160495 |
| 101 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.35032030 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34749190 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.32372769 |
| 104 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.30685231 |
| 105 | Tight junction_Homo sapiens_hsa04530 | 0.29888571 |
| 106 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.29740579 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29606515 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28722958 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27575622 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27385403 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.23385566 |
| 112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.22633377 |

